- 2009-06-10 Bayhill Therapeutics Enters Exclusive, Worldwide Collaboration with Genentech for BHT-3021 in Type 1 Diabetes
- 2009-06-10 PharmaMar licenses Kahalalide F to Medimetriks Pharmaceuticals for uses outside of Oncology/Neurology
- 2009-06-10 Amarna Therapeutics B.V. and TNO announce SVac research and development partnership
- 2009-06-10 BioSeek and Merck Serono Extend 2008 Agreement - Compound Profiling Collaboration Continues into 2012
- 2009-06-10 Bio-Bridge Science Signs a Contract to Form a Cell-Culture Medium Joint Venture in Beijing, China
- 2009-06-10 Taro and Quinnova Announce Agreement to Co-Promote "Neosalus" and "Cleanse & Treat" in the United States
- 2009-06-10 Metabasis Therapeutics Announces That Its Collaborator Merck & Co., Inc. Has Selected a Lead AMPK Activator for Late Preclinical Development and Has Agreed to Make a One-Time Payment for All Remaining Financial Obligations
- 2009-06-09 CSL and Talecris Biotherapeutics Agree to Terminate Merger Agreement
- 2009-06-09 Penwest and Endo Grant Valeant Pharmaceuticals Exclusive License to Market Opana(r) ER in Canada, Australia and New Zealand
- 2009-06-09 Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
PharmaDeals
the world’s most comprehensive pharmaceutical and biotech deals database.
Subscribe to PharmaDeals
Click here to gain access to the PharmaDeals database and Review publication